Better treatments that cost more: The dilemma

Gynecologic Oncology

Volumn 78, Issue 1, 2000, Pages 1-2

  Elit, Laurie ^a,b,c   Gafni, Amiram ^a   Levine, Mark N ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b JURAVINSKI CANCER CENTRE   (Canada)

^c ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; ECONOMIC EVALUATION; EDITORIAL; FEMALE; HEALTH CARE POLICY; HOSPITAL COST; HUMAN; MULTICENTER STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX CANCER;

EID: 0033937899     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.5885     Document Type: Editorial

References (11)

1. CW Whitney W Sause BN Bundy Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB–IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1999 1339 1348
2. M Morris PJ Eifel J Lu PW Grisby C Levenback RE Stevens M Rotman DM Gershenson Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high risk cervical cancer: A randomized Radiation Therapy Oncology Group clinical trial N Engl J Med 340 1999 1137 1143
3. PG Rose BN Bundy EB Watkins Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153
4. WA Peters III PY Liu RJ Barrett W Gordon Jr R Stock JF Berek PJ DiSaia L Souhami P Grisby DS Alberts Cisplatin and 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive in high-risk early stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: Report of a phase III intergroup study Gynecol Oncol 72 1999 443
5. HM Keys BM Bundy FB Stehman LI Muderspach WE Chafe CL Suggs JL Wlaker D. Gersell A comparison of weekly cisplatin during radiation therapy versus irradiation alone each followed by adjuvant hysterectomy in bulky stage IB cervicalcarcinomaA randomized trial of the Gynecologic Oncology Group N Engl J Med 340 1999 1154 1161
6. Pearcey, R, G, Brundage, M, D, Crouin, P, Jeffrey, J, Johnston, D, Lukka, H, MacLean, G, Souhami, L, Stuart, G, Tu, D, A clinical trial comparing concurrent cisplatin and radiation therapy versus radiation alone for locally advanced squamous cell carcinoma of the cervix carried out by the National Cancer Institute of Canada Clinical Trials Group, A0CO, 19; 2000, Abstract 1497
7. PG Rose PT Lappas Analysis of the cost effectiveness of concurrent cisplatin-based chemoradiation in cervical cancer: Implications from five randomized trials Gynecol Oncol 78 2000 3 6
8. MF Drummond BJ O'Brien GL Stoddart GW Torrance Methods for the Economic Evaluation of Health Care Programmes Oxford Medical Publications 1997 96 138
9. KK Hansen J Zwanzizer Marginal costs in general acute care hospitals: A comparison among California, New York and Canada Health Econ 5 1996 195 216
10. A Gafni Economic evaluation. Journal of health care interventions: An economist perspective ACP J Club 124 1996 A12 A14
11. L Elit A Gafni MN Levine Economic and policy implications of adopting paclitaxel as first-line therapy for advanced ovarian cancer: An Ontario perspective J Clin Oncol 15 1997 632 639